Cancer Center Basic Research Programs
The Basic Research program includes characterizing myeloma and tumor-specific T cells, identifying novel myeloma-associated antigens and better methods for immunotherapy, investigating the cross-talk between the tumor microenvironment and the immune system in malignancy, exploring immunotherapies using novel myeloma antigens and clinical trials.
Qing Yi, MD, PhD
Protein from multiple myeloma cells offers novel treatment approach
A research study by Qing Yi, MD, PhD, and colleagues showed that a protein derived from multiple myeloma cells promoted the immunosuppressive function of white blood cells, offering potential for multiple myeloma treatment. Learn more.